Nine publications studied other populations which included patients with cystic fibrosis (2), SERPINA1 deficiency (2), cotton and grain workers (2), lung cancer (1), fire fighters (1) and post myocardial infarction (MI) patients (1). This evidence concerns the gene SERPINA1 and lung carcinoma.